Current Locations:Home > PRODUCTS > IBI302

IBI302-A Bispecific Monoclonal Antibody for Oncology
IBI302 is a bispecific antibody that blocks two targets simultaneously, allowing it to potentially impact disease formation and progression inthe treatment of multiple solid tumors and ophthalmology diseases in a way that may be significantly superior to current therapies. Innovent owns global IP rights for the IBI302 molecule.

Copyright © 2011- Innovent Biologics, Inc.
Powered by RuiXi